Table 4.
Characteristics of patients undergoing endovascular therapy.
| No. | Sex | Age | Cause | T-PA(d) | Location | Size (cm) | Nd(mm) | Treatment | Reintervention | Follow-up time (m) | AE |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 69 | T | 7 | SGA | 2.4 × 1.3 | 2 | E | No | 7.9 | None |
| 2 | M | 52 | T | 30 | SA | 7.1 × 3.5 | 4 | S | No | 11.2 | None |
| 3 | M | 48 | T | 35 | PA | 2.6 × 1.5 | 3.8 | E | No | 43.5 | None |
| 4 | M | 71 | I | 2 | SFA | 2.6 × 1.7 | 2 | S | No | 6.4 | None |
| 5 | M | 45 | T | 10 | PTA | 8.6 × 4.5 | 5 | S | No | 47.6 | None |
| 6 | M | 60 | T | 60 | SFA | 12.1 × 11.6 | 4.5 | S | No | 46.2 | None |
| 7 | M | 39 | T | 7 | PTA | 7.2 × 3.8 | 4 | E | No | 50.3 | None |
| 8 | M | 43 | T | 4 | DFA | 5.2 × 3.0 | 3 | E | No | 36 | None |
| 9 | M | 51 | T | 180 | SFA | 2.6 × 1.6 | 3 | E | No | 73.4 | None |
| 10 | M | 55 | I | 4 | CFA | 4.0 × 3.1 | 8 | S | No | 63.6 | None |
| 11 | M | 59 | T | 3 | SA | 7.2 × 5.3 | 5.7 | S | No | 63.8 | None |
| 12 | M | 53 | T | 3 | CFA | 4.6 × 3.6 | 5 | S | Yes | 65.3 | None |
| 13 | M | 65 | T | 7 | SA | 4.4 × 2.9 | 3.8 | S | No | 71.7 | None |
| 14 | F | 55 | T | 30 | IGA | 5.3 × 3.1 | 3 | E | No | 72.8 | None |
| 15 | M | 51 | T | 5 | SA | 4.4 × 1.8 | 3.5 | S | No | 49.8 | None |
| 16 | M | 49 | T | 4 | SA | 5.3 × 4.6 | 4 | S | No | 81.1 | None |
| 17 | M | 42 | T | 180 | SA | 5.1 × 4.6 | 4 | S | No | 4.5 | None |
| 18 | F | 45 | T | 730 | SA | 2.3 × 1.3 | 3 | S | No | 117.9 | None |
F= Female; M = Male; T = Traumatic; I= Iatrogenic; SGA= Superior gluteal artery; SA= Subclavian artery; T-PA= Time from injury to diagnosis of pseudoaneurysm; PA= Peroneal artery; SFA= Superficial femoral artery; PTA= Posterior tibial artery; DFA = Deep femoral artery; CFA= Common femoral artery; IGA= Inferior gluteal artery; E = Embolization; S= Stent; Nd= Neck diameter; AE = Adverse events.